Adalimumab

Overview

4.7 out of 5 (94 Reviews)

Credits

1.50

Post Assessment Questions

6

Start Date

1 Jan 2021

Last Review Date

12 Nov 2023

Expiration Date

31 Dec 2023

Estimated Time To Finish

90 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Adalimumab is a fully human, recombinant monoclonal antibody with high affinity and was the third tumor necrosis factor-alpha (TNF-α) inhibitor. Adalimumab is used to treat various autoimmune conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn disease, and ulcerative colitis. The original adalimumab molecule received its initial approval from the U.S. Food and Drug Administration (FDA) for treating rheumatoid arthritis. This activity comprehensively reviews the indications, mechanism of action, administration, potential adverse effects, and contraindications of adalimumab, providing the interprofessional healthcare team with the necessary information to effectively utilize the drug and treat certain autoimmune conditions. This topic also emphasizes the warnings, precautions, and potential drug-drug interactions associated with adalimumab when administered to patients with autoimmune disorders.


Target Audience

This activity has been designed to meet the educational needs of physicians.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate indications for adalimumab therapy based on the patient's medical history, clinical presentation, and relevant diagnostic findings.

  • Implement a standardized dosing and monitoring protocol for patients initiating adalimumab therapy, ensuring adherence to recommended treatment regimens.

  • Assess patient response to adalimumab treatment, including evaluating changes in disease activity, symptoms, and adverse events.

  • Collaborate with multidisciplinary healthcare teams, including rheumatologists, gastroenterologists, nurses, and pharmacists, to provide comprehensive patient care, improve patient outcomes, and address complex patient needs.

Disclosures

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they or their immediate family may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CUSOM for resolution, to ensure fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

CUSOM will identify, review, and resolve all conflicts of interest that faculty, authors, activity directors, planners, managers, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for authors, editors, planners, peer reviewers, and/or relevant staff is provided with this activity.

Continuing Education Accreditation Information

 

 

The Campbell University Jerry M. Wallace School of Osteopathic Medicine (CUSOM) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. CUSOM designates this enduring material for a maximum of 1.50 AOA Category 1 B Credits and will report CME credits commensurate with the extent of the physician's participation in the activity.

Cancellation Policy: Cancellations must be received in writing and a money back guarantee is provided if not completely satisfied.

  • StatPearls and CUSOM reserve the right to cancel any course due to unforeseen circumstances. StatPearls and CUSOM will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Equal Opportunity

  • StatPearls and CUSOM are Equal Opportunity / Affirmative Action / Equal Access Institutions. 

Medium or Media Used:

  • Computer Requirements:  Internet Access
  • E-mail Address

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the required accreditation information:  Target audience, learning objectives and disclosure information.
  3. Complete the entire self-study activity.
  4. Complete the post-test assessments.
  5. Successfully pass the post-test with a minimum score of 100%.
  6. Complete the evaluation form.
  7. Obtain a certificate.

StatPearls and CUSOM adheres to AOA Standards regarding commercial support of continuing medical education. It is the policy of StatPearls and Campbell that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that authors and editors will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made prior to starting the activity.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

This course is intended for osteopathic physicians who wish to earn AOA CME credit. Take this version of the course to ensure you receive appropriate credit.

 

 
 

Reviews

Hurline S. on 10/6/2021

Kathleen D. on 10/26/2021

patricia h. on 11/11/2021

Thank you.

Douglas T. on 12/5/2021

Raul C. on 12/6/2021

Hope H. on 12/17/2021

Robin Z. on 1/25/2022

devin n. on 2/26/2022

Rachel d. on 3/3/2022

Paul F. on 4/5/2022

YOUN JU L. on 4/19/2022

Paul H. on 5/4/2022

Shelia C. on 5/14/2022

Deanna K. on 5/22/2022

Stephen A. on 5/31/2022

Ejaz J. on 6/5/2022

Nathan S. on 6/19/2022

Nancy F. on 6/27/2022

Richard M. on 7/14/2022

Shannon j. on 7/18/2022

Clifford A. on 8/6/2022

Steve R. on 8/6/2022

Nicole G. on 9/24/2022

Maylin G. on 10/10/2022

Dr.NIRMALA M. on 10/30/2022

Theodore B. on 11/3/2022

James A. on 11/24/2022

Amr K. on 11/30/2022

Nextgen l. on 12/4/2022

Holly J. on 12/12/2022

long h. on 12/15/2022

efstathia c. on 12/26/2022

Ravi J. on 12/31/2022

jubril o. on 2/8/2023

Stephanie F. on 2/15/2023

Kristy T. on 2/15/2023

Rose F. on 2/28/2023

Joanne S. on 3/13/2023

Alexander D. on 3/27/2023

Kinga V. on 4/16/2023

Amber S. on 6/13/2023

Mary Y. on 7/12/2023

Jennifer F. on 7/15/2023

Reena R. on 8/7/2023

Ravi J. on 9/11/2023

John T. on 9/22/2023

Lyonschvala n. on 9/24/2023

Please submit my MOC points to the American Board of Internal Medicine ABIM for Matthew Ornstein MD

Matthew O. on 9/24/2023

ROSEMARY D. on 10/7/2023

Stephen N. on 10/24/2023

robert s. on 10/30/2023

larry I. on 11/9/2023

Larry M. on 11/10/2023

no mention of anti adalimumab ab formation

William S. on 11/12/2023

Elisabeth I. on 11/23/2023

Aimee G. on 11/27/2023

Melissa B. on 11/29/2023

kristi f. on 11/30/2023

Carolyn B. on 12/3/2023

Drew H. on 12/5/2023

Svetlana T. on 12/11/2023

Scott S. on 12/18/2023

Aviva Z. on 12/19/2023

Scott H. on 12/21/2023

Arkam R. on 12/24/2023

Park C. on 12/25/2023

Aurelio T. on 12/27/2023

Dr. Amer J. on 12/31/2023

Antonio D. on 12/31/2023

Erika G. on 1/1/2024

Kritsen Z. on 1/2/2024

Revathi K. on 1/5/2024

Michael A. on 1/8/2024

Raymond E. on 1/9/2024

Wojciech F. on 1/10/2024

George M. on 1/18/2024

Patricia S. on 1/31/2024

Truclinh N. on 2/20/2024

Shari M. on 2/23/2024

Nicole T. on 2/23/2024

Alexander H. on 3/1/2024

THERESA M. on 3/4/2024

Mark G. on 3/13/2024

Christopher K. on 3/15/2024

Angela P. on 3/18/2024

Kaman C. on 3/21/2024

JEANNETTE A. on 3/24/2024

Laura l. on 3/30/2024

Nithya P. on 3/30/2024

James R. on 3/30/2024

Mohammad I. on 3/31/2024

Tiffany M. on 4/5/2024

larry m. on 4/6/2024

cyrus i. on 4/11/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$39 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user